Search Results Search Sort by RelevanceMost Recent State of the Art and Science Aug 2020 American College of Preventive Medicine Statement on Prioritizing Prevention in Opioid Research Hunter Jackson Smith, MD, MPH, MBE, Elizabeth Salisbury-Afshar, MD, MPH, Bob Carr, MD, MPH, and Stephanie Zaza, MD, MPH Opioid use research has focused mainly on treatment and overdose responses. Clinically and ethically, these priorities should change. AMA J Ethics. 2020;22(8):E687-694. doi: 10.1001/amajethics.2020.687. Policy Forum Aug 2020 Ethical Imperatives to Overcome Stigma Against People With Substance Use Disorders VADM Jerome M. Adams, MD, MPH and Nora D. Volkow, MD Responding to opioid use disorder as a US public health crisis requires all clinicians to recognize addiction as a treatable disease. AMA J Ethics. 2020;22(8):E702-708. doi: 10.1001/amajethics.2020.702. Policy Forum Aug 2020 How Structural Violence, Prohibition, and Stigma Have Paralyzed North American Responses to Opioid Overdose Mark Tyndall, MD, ScD and Zoë Dodd, MES Driven by toxic, unpredictable, unregulated supply, drug overdose deaths are rampant. Policies that support the war on drugs have to change to be helpful. AMA J Ethics. 2020;22(8):E723-728. doi: 10.1001/amajethics.2020.723. Case and Commentary May 2022 Should Clinicians Prescribe Non-FDA Regulated Dietary Supplements When Caring for Children With Hypovitaminosis D? Ethan A. Mezoff, MD, Hannah Hays, MD, and Ala Shaikhkhalil, MD Children with micronutrient deficiency might need supplementation, sometimes in irregularly high doses. AMA J Ethics. 2022;24(5):E353-360. doi: 10.1001/amajethics.2022.353. Medical Education Nov 2002 Cost-Effective Prescribing Susanna Smith Virtual Mentor. 2002;4(11):338-340. doi: 10.1001/virtualmentor.2002.4.11.puhl1-0211. Case and Commentary Jun 2022 How Should Relief Organizations Fund Care of Patient-Asylees Who Have Cancer? Farrah J. Mateen, MD, PhD and Paul B. Spiegel, MD, MPH Several clinical and ethical dilemmas arise when caring for refugees with complex, costly, and chronic conditions. AMA J Ethics. 2022;24(6):E457-462. doi: 10.1001/amajethics.2022.457. Case and Commentary Jun 2022 كيف ينبغي لمنظمات الإغاثة أن تمول رعاية المرضى- اللاجئين المصابين بالسرطان؟ Farrah J. Mateen, MD, PhD and Paul B. Spiegel, MD, MPH AMA J Ethics. 2022;E457-462. doi: 10.1001/amajethics.2022.457. Podcast Apr 2022 Author Interview: “Should Clinicians Be Activists?” Dr Kristen N. Pallok joins Ethics Talk to discuss her article, coauthored with Dr David A. Ansell: “Should Clinicians Be Activists?” Case and Commentary Apr 2022 ¿Los médicos deben ser activistas? Kristen N. Pallok, MD and David A. Ansell, MD, MPH AMA J Ethics. 2022;E254-260. doi: 10.1001/amajethics.2022.254. Case and Commentary Apr 2022 ¿Cómo debe responder la atención médica estadounidense a las necesidades de salud de la comunidad latina? Chiamaka Sonubi, MD, Efren Flores, MD, and Lucy Spalluto, MD, MPH AMA J Ethics. 2022;E261-266. doi: 10.1001/amajethics.2022.261. Pagination First page « First Previous page ‹ Previous … Page 5 Page 6 Page 7 Page 8 Current page 9 Page 10 Page 11 Page 12 Page 13 … Next page Next › Last page Last »
State of the Art and Science Aug 2020 American College of Preventive Medicine Statement on Prioritizing Prevention in Opioid Research Hunter Jackson Smith, MD, MPH, MBE, Elizabeth Salisbury-Afshar, MD, MPH, Bob Carr, MD, MPH, and Stephanie Zaza, MD, MPH Opioid use research has focused mainly on treatment and overdose responses. Clinically and ethically, these priorities should change. AMA J Ethics. 2020;22(8):E687-694. doi: 10.1001/amajethics.2020.687.
Policy Forum Aug 2020 Ethical Imperatives to Overcome Stigma Against People With Substance Use Disorders VADM Jerome M. Adams, MD, MPH and Nora D. Volkow, MD Responding to opioid use disorder as a US public health crisis requires all clinicians to recognize addiction as a treatable disease. AMA J Ethics. 2020;22(8):E702-708. doi: 10.1001/amajethics.2020.702.
Policy Forum Aug 2020 How Structural Violence, Prohibition, and Stigma Have Paralyzed North American Responses to Opioid Overdose Mark Tyndall, MD, ScD and Zoë Dodd, MES Driven by toxic, unpredictable, unregulated supply, drug overdose deaths are rampant. Policies that support the war on drugs have to change to be helpful. AMA J Ethics. 2020;22(8):E723-728. doi: 10.1001/amajethics.2020.723.
Case and Commentary May 2022 Should Clinicians Prescribe Non-FDA Regulated Dietary Supplements When Caring for Children With Hypovitaminosis D? Ethan A. Mezoff, MD, Hannah Hays, MD, and Ala Shaikhkhalil, MD Children with micronutrient deficiency might need supplementation, sometimes in irregularly high doses. AMA J Ethics. 2022;24(5):E353-360. doi: 10.1001/amajethics.2022.353.
Medical Education Nov 2002 Cost-Effective Prescribing Susanna Smith Virtual Mentor. 2002;4(11):338-340. doi: 10.1001/virtualmentor.2002.4.11.puhl1-0211.
Case and Commentary Jun 2022 How Should Relief Organizations Fund Care of Patient-Asylees Who Have Cancer? Farrah J. Mateen, MD, PhD and Paul B. Spiegel, MD, MPH Several clinical and ethical dilemmas arise when caring for refugees with complex, costly, and chronic conditions. AMA J Ethics. 2022;24(6):E457-462. doi: 10.1001/amajethics.2022.457.
Case and Commentary Jun 2022 كيف ينبغي لمنظمات الإغاثة أن تمول رعاية المرضى- اللاجئين المصابين بالسرطان؟ Farrah J. Mateen, MD, PhD and Paul B. Spiegel, MD, MPH AMA J Ethics. 2022;E457-462. doi: 10.1001/amajethics.2022.457.
Podcast Apr 2022 Author Interview: “Should Clinicians Be Activists?” Dr Kristen N. Pallok joins Ethics Talk to discuss her article, coauthored with Dr David A. Ansell: “Should Clinicians Be Activists?”
Case and Commentary Apr 2022 ¿Los médicos deben ser activistas? Kristen N. Pallok, MD and David A. Ansell, MD, MPH AMA J Ethics. 2022;E254-260. doi: 10.1001/amajethics.2022.254.
Case and Commentary Apr 2022 ¿Cómo debe responder la atención médica estadounidense a las necesidades de salud de la comunidad latina? Chiamaka Sonubi, MD, Efren Flores, MD, and Lucy Spalluto, MD, MPH AMA J Ethics. 2022;E261-266. doi: 10.1001/amajethics.2022.261.